Tag page - INFANT FORMULA

The Food and Drug Administration (FDA) on Tuesday, Jan. 20, warned infant formula manufacturers that they remain fully accountable for product safety despite the absence of established safety limits, stressing that infant safety is “non-negotiable” amid the voluntary recall of certain products...

The Food and Drug Administration (FDA) has received 25 reports linked to recalled NAN OPTIPRO and NANKID OPTIPRO infant formula products, with 18 involving health concerns observed by parents or caregivers after consumption. In an advisory on January 16, the FDA said that “as of 15 January 2026,...

The Food and Drug Administration (FDA) said it is conducting an ongoing investigation to determine the scope of the issue and assess any potential safety implications following the voluntary recall of select infant formula products by Nestlé Philippines. In a statement released on Monday, Jan....